Bionomics Ltd. | |
Stock Exchange | Australian Stock Exchange |
EPS |
AUD0.06 |
Market Cap |
AUD22.33 M |
Shares Outstanding |
544.69 M |
Public Float |
504.63 M |
Address |
31 Dalgleish Street Thebarton South Australia (SA) 5031 Australia |
Employees | - |
Website | http://www.bionomics.com.au |
Updated | 07/08/2019 |
Bionomics Ltd. is a clinical stage biopharmaceutical company, which discovers and develops therapeutics for cancer and diseases of the central nervous system. The company operates through following segments: Drug Discovery and Development, and Contract Services. The Drug discovery and development segment engages in the discovery, development and commercialization of compounds to match a target product profile. |